Padagis Seeks To Challenge Hikma’s Kloxxado

Naloxone 8mg Nasal Spray Is Among Firm’s Latest First-To-File Targets

 
• By David Wallace
  
Padagis has filed an ANDA for a naloxone 8mg nasal spray
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin